My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Quest Diagnostics (NY:DGX)

235.59 -0.34 (-0.15%)

Streaming Delayed Price Updated: 1:37 PM EDT, Jul 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

This Snap Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

October 23, 2024

Via Benzinga

What Analysts Are Saying About Quest Diagnostics Stock ↗

October 23, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics ↗

October 23, 2024

Via Benzinga

Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday ↗

October 22, 2024

Via Benzinga

Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025 ↗

October 22, 2024

Quest Diagnostics reports strong Q3 with 8.5% sales growth, raises 2024 revenue guidance to $9.80 billion-$9.85 billion, citing acquisitions and new customer wins.

Via Benzinga

Earnings Preview: Quest Diagnostics ↗

October 21, 2024

Via Benzinga

Looking Into Quest Diagnostics's Recent Short Interest ↗

October 21, 2024

Via Benzinga

Decoding 7 Analyst Evaluations For Quest Diagnostics ↗

October 07, 2024

Via Benzinga

What Analysts Are Saying About Quest Diagnostics Stock ↗

August 27, 2024

Via Benzinga

Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday ↗

October 07, 2024

Via Benzinga

Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗

August 26, 2024

Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...

Via Benzinga

8 Health Care Stocks With Whale Alerts In Today's Session ↗

August 01, 2024

Via Benzinga

LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector ↗

August 01, 2024

LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024...

Via Benzinga

Uncovering Dividend Opportunities with NYSE:DGX. ↗

July 25, 2024

Analyzing QUEST DIAGNOSTICS INC (NYSE:DGX)'s Dividend Potential.

Via Chartmill

5 Analysts Assess Quest Diagnostics: What You Need To Know ↗

July 24, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics ↗

July 05, 2024

Via Benzinga

Quest Diagnostics' Q2 Earnings Performance Suggests Stable Stock, Modest Growth Ahead, Analyst Says ↗

July 23, 2024

Quest Diagnostics reported a second-quarter adjusted EPS of $2.35, surpassing the consensus of $2.34. Sales rose 2.5% year-over-year to $2.39 billion. The company raised its fiscal year 2024 revenue...

Via Benzinga

Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday? ↗

July 23, 2024

Tuesday's Wall Street session was mixed, with small-caps outperforming large-caps as investors awaited earnings from Alphabet Inc. and Tesla Inc.

Via Benzinga

DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q2 2024 ↗

July 23, 2024

DGX stock results show that Quest Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

How Is The Market Feeling About Quest Diagnostics? ↗

June 27, 2024

Via Benzinga

Peering Into Quest Diagnostics's Recent Short Interest ↗

June 10, 2024

Via Benzinga

Analyst Scoreboard: 7 Ratings For Quest Diagnostics ↗

May 30, 2024

Via Benzinga

US Stock Futures Little Changed As Traders Brace For Q2 Reports From Alphabet, Tesla: 'There Remains Strong Fundamental Support For Large Caps,' Says Economist ↗

July 23, 2024

The market mood turned jittery after Monday’s rebound, with index futures trading on either side of the unchanged line early Tuesday. The apprehensions reflect uncertainties regarding geopolitics,...

Via Benzinga

Topics Artificial Intelligence

Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy

July 18, 2024

From Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology

Via GlobeNewswire

How Is The Market Feeling About Quest Diagnostics? ↗

May 24, 2024

Via Benzinga

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗

July 21, 2024

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Via Benzinga

EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy ↗

July 18, 2024

Haystack Oncology, a Quest Diagnostics company, and Lisata Therapeutics collaborate to use Haystack MRD technology in a study of certepetide plus chemotherapy for metastatic pancreatic cancer, focusing...

Via Benzinga

S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday ↗

July 05, 2024

Via Benzinga

Topics Stocks

Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests

June 18, 2024

Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including

Via MarketBeat

Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High ↗

May 15, 2024

Cheating on drug tests among American workers has reached a 30-year high, with Quest Diagnostics Inc. reporting 31,000 tampered samples out of 5.5 million in 2023. The rise in synthetic urine use and...

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.